Thromb Haemost 2008; 100(01): 60-68
DOI: 10.1160/TH07-03-0222
Platelets and Blood Cells
Schattauer GmbH

Effects of von Willebrand factor concentration and platelet collision on shear-induced platelet activation

Zhenyue Gao
1   Bioengineering Department of Beijing University of Aeronautics and Astronautics, Beijing, China
,
Fang Liu
2   Jiangsu Institute of Hematology, Suzhou, China
,
Ziqiang Yu
2   Jiangsu Institute of Hematology, Suzhou, China
,
Xia Bai
2   Jiangsu Institute of Hematology, Suzhou, China
,
Chun Yang
1   Bioengineering Department of Beijing University of Aeronautics and Astronautics, Beijing, China
,
Fengyuan Zhuang
1   Bioengineering Department of Beijing University of Aeronautics and Astronautics, Beijing, China
,
Changgeng Ruan
2   Jiangsu Institute of Hematology, Suzhou, China
› Institutsangaben
Financial support: This work was supported by a grant from the National Natural Sciences Foundation of PR China (No. 10402002 and 30670904), and a Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 200356).
Weitere Informationen

Publikationsverlauf

Received 26. März 2007

Accepted after major revision 06. Mai 2008

Publikationsdatum:
22. November 2017 (online)

Summary

The binding of plasma von Willebrand factor (vWF) to platelet glycoprotein (GP) Ibα in a high shear stress field, and subsequent integrin-GPIIb/IIIa-vWF conjunction induces platelet aggregation (SIPA). However, the specific biomechanical mechanism of the vWF-GPIb interaction still remains to be elucidated. A parallel-plate rectangular flow chamber was built to simulate a stenopeic artery flow pattern. Using the flow chamber, we examined shear- induced platelet activation (SIPAct) at different vWF concentrations (5–25 µg/ml) and several simulated stenotic high shear rates. P-selectin expression on the platelets and annexin V binding to the platelets were used as two markers of platelet activation. At different localized shear rates (3,000 s-1–9,500 s-1), the percentage of annexin V and P-selectin positive cells increased from 8.3 ± 0.4% to 22.3 ± 1.8% ( p 0.05) and from 17.4 ± 0.5% to 33.5 ± 2.5% (p 0.05),respectively. As the vWF concentration increased from 5 µg/ml to 25 µg/ml, the annexinV binding rate increased from 7.2 ± 0.6% to 53.4 ± 3.8% (p 0.05), and P-selectin expression increased from 16.5 ± 1.2% to 65.9 ± 5.2% (p 0.05). A test in a uniform shear field using cone-plate viscometer rheometry showed that the platelet activation rate was proportional to the platelet concentration. This result suggests that platelet collision is one of the impact factors of SIPAct.

 
  • References

  • 1 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297.
  • 2 Kroll MH, Hellums JD, McIntire LV. et al. Platelets and shear stress. Blood 1996; 88: 1525-1541.
  • 3 Ikeda Y, Murata M, Goto S. Von Willebrand factordependent shear-induced platelet aggregation: basic mechanisms and clinical implications. Ann NY Acad Sci 1997; 811: 325-336.
  • 4 Shankaran H, Alexandridis P, Neelamegham S. Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension. Blood 2003; 101: 2637-2645.
  • 5 Ikeda Y, Handa M, Kamata T. et al. Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation. Thromb Haemost 1993; 69: 496-502.
  • 6 O'Brien JR, Salmon GP. Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long bleeding time in von Willebrand's disease. Blood 1987; 70: 1354-1361.
  • 7 Peterson DM, Stathopoulos NA, Giorgio TD. et al. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 1987; 69: 625-628.
  • 8 Andrew DB. Plasma von Willebrand factor, thrombosis, and the endothelium: The first 30 years. Thromb Haemost 2006; 95: 49-55.
  • 9 Ruggeri ZM. von Willebrand factor. J Clin Invest 1997; 99: 559-563.
  • 10 Sadler JE. Biochemistry and genetics of von Willebrand factor. Ann Rev Biochem 1998; 67: 395-424.
  • 11 Ruggeri ZM. von Willebrand factor and the mechanisms of platelet function. Springer: 1998
  • 12 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297.
  • 13 James KH, Robert ES, Gwen AM. et al. Pharmacologic inhibition of platelet vWF-GPIbα interaction prevents coronary artery thrombosis. Thromb Haemost 2006; 95: 469-475.
  • 14 Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature 1979; 279: 636-638.
  • 15 Schoenwaelder SM, Hughan SC, Boniface K. et al. RhoA sustains integrin αIIbβ3 adhesion contacts under high shear. J Biol Chem 2002; 277: 14738-14746.
  • 16 Oury C, Sticker E, Cornelissen H. et al. ATP augments von Willebrand factor-dependent shear-induced platelet aggregation through Ca2+-calmodulin and myosin light chain kinase activation. J Biol Chem 2004; 279: 26266-26273.
  • 17 Belval TK, Hellums JD. Analysis of shear-induced platelet aggregation with population balance mathematics. Biophys J 1986; 50: 479-487.
  • 18 Holme PA, Ørvim U, Hamers MJAG. et al. Shearinduced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997; 17: 646-653.
  • 19 Goto S, Ikeda Y, Saldívar E. et al. Distinct Mechanisms of Platelet Aggregation as a Consequence of Different Shearing Flow Conditions. J Clin Invest 1998; 101: 479-486.
  • 20 Depraetere H, Ajzenberg N, Girma JP. et al. Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor. Blood 1998; 91: 3792-3799.
  • 21 Pontiggia L, Steiner B, Ulrichts H. et al. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIbα. Thromb Haemost 2006; 96: 774-780.
  • 22 Wang JS. Intense exercise increases shear-induced platelet aggregation in men through enhancement of von Willbrand factor binding, glycoprotein IIb/IIIa activation, and P-selectin expression on platelets. Eur J Appl Physiol 2004; 91: 741-747.
  • 23 van Mourik JA, Mochtar IA. Purification of human antihemophilic factor (factor VIII) by gel chromatography. Biochim Biophys Acta 1970; 221: 677-679.
  • 24 Ruan CG, Du XP, Xi XD. et al. A murine antiglycoprotein Ib complex monoclonal antibody, SZ2, inhibits platelet aggregation induced by both ristocetin and collagen. Blood 1987; 69: 570-577.
  • 25 Kasirer-Friede A, Cozzi MR, Mazzucato M. et al. Signaling through GP Ib-IX-V activates αIIbβ3 independently of other receptors. Blood 2004; 103: 3403-3411.
  • 26 Mazzucato M, Cozzi MR, Pradella P. et al. Distinct roles of ADP receptors in von Willebrand factor-mediated platelet signaling and activation under high flow. Blood 2004; 104: 3221-3227.
  • 27 Oury C, Toth-Zsamboki E, Vermylen J. et al. P2X1-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen. Blood 2002; 100: 2499-2505.
  • 28 Mazzucato M, Pradella P, Cozzi MR. et al. Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibamechanoreceptor. Blood 2002; 100: 2793-2800.
  • 29 Dorsam RT, Kim S, Murugappan S. et al. Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways. Blood 2005; 105: 2749-2756.
  • 30 Wunder B, Melzer S. Interlayer vacancy characterization of synthetic phlogopitic micas by IR spectroscopy. Eur J Mineral 2002; 14: 1129-1138.
  • 31 Goto S, Salomon DR, Ikeda Y. et al. Characterization of the unique mechanism mediating the sheardependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995; 270: 23352-23361.
  • 32 Dachary-Prigent J, Freyssinet JM, Pasquet JM. et al. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81: 2554-2565.
  • 33 Merten M, Chow T, Hellums TD. et al. A new role for P-selectin in shear-induced platelet aggregation. Circulation 2000; 102: 2045-2050.
  • 34 Richter H. Rohrhydraulik. Springer-Verlag: 1971
  • 35 Muggli R, Baumgartner HR, Tschopp TB. et al. Automated microdensitometry and protein assays as a measure for platelet adhesion and aggregation on collagen-coated slides under controlled flow conditions. J Lab Clin Med 1980; 95: 195-207.
  • 36 Brian S. Perry's Chemical Engineer's Handbook. 6th Ed. New York: McGraw-Hill Book Co; 1984. 5 23-25.
  • 37 Fukuyama M, Sakai K, Itagaki I. et al. Continuous measurement of shear-induced platelet aggregation. Thromb Res 1989; 54: 253-260.
  • 38 Chow TW, Hellums JD, Moake JL. et al. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood 1992; 80: 113-120.
  • 39 Osende JI, Fuster V, Lev EI. et al. Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests: Relevance for monitoring long-term glycoprotein IIb/IIIa inhibition. Circulation 2001; 103: 1488-1491.
  • 40 Shenkman B, Schneiderman J, Tamarin I. et al. Testing the effect of GPIIb-IIIa antagonist in patients undergoing carotid stenting: correlation between standard aggregometry, flow cytometry and the cone and plate(let) analyzer (CPA) methods. Thromb Res 2001; 102: 311-317.
  • 41 Sutera SP, Nowak MD, Joist JH. et al. A programmable, computer-controlled cone-plate viscometer for the application of pulsatile shear stress to platelet suspensions. Biorheology 1988; 25: 449-459.
  • 42 Smoluchowski MV. Versuch einer mathematischen theorie der koagulationskinetik kolloider losungen. Z Phys Chem 1917; 92: 129-168.
  • 43 Levich VG. Physicochemical hydrodynamics. Englewood Cliffs, NJ: Prentice Hall; 1962
  • 44 Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Heart 1991; 66: 351-355.
  • 45 Johansson L, Jansson JH, Boman K. et al. Prospective study on soluble thrombomodulin and von Willebrand factor and the risk of ischemic and hemorrhagic stroke. Thromb Haemost 2002; 87: 211-217.
  • 46 Elena IS, Dmitry AK, Nadezhda YP. et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425-434.
  • 47 Zwaal RF, Schroit AJ. Pathophysiologic impli-cationsof membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-1132.
  • 48 Hsu-Lin S, Berman CL, Furie BC. et al. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombinactivated platelets. J Biol Chem 1984; 259: 9121-9126.
  • 49 Belval T, Hellums JD, Solis RT. The kinetics of platelet aggregation induced by fluidshearing stress. Microvasc Res 1984; 28: 279-288.
  • 50 Belval TK, Hellums JD. Analysis of shear-induced platelet aggregation with population balance mathematics. Biophys J 1986; 50: 479-487.